MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹25 Cr | ₹17 Cr | ₹24 Cr | ₹14 Cr | ₹21 Cr |
What is the latest Total Non-Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹25 Cr |
Mar2023 | ₹17 Cr |
Mar2022 | ₹24 Cr |
Mar2021 | ₹14 Cr |
Mar2020 | ₹21 Cr |
How is Total Non-Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹25 Cr | 44.30 | |
Mar2023 | ₹17 Cr | -28.52 | |
Mar2022 | ₹24 Cr | 79.29 | |
Mar2021 | ₹14 Cr | -35.72 | |
Mar2020 | ₹21 Cr | - |
Compare Total Non-Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM GLOBAL ENTERPRISE | ₹481.9 Cr | 3.5% | 11.2% | NA | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,934.7 Cr | -5.8% | -6.3% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,436.8 Cr | -5.7% | -15.3% | 32.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,264.3 Cr | -1.5% | 0.4% | -16.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,435.5 Cr | -2% | -1.8% | -33.7% | Stock Analytics | |
INDO US BIOTECH | ₹307.9 Cr | 1.5% | 1.6% | -27% | Stock Analytics |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM GLOBAL ENTERPRISE | 3.5% |
11.2% |
|
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses